8 results match your criteria Palliative Care of the Patient With Advanced Gynecologic Cancer

  • Page 1 of 1

Comparing the distress thermometer (DT) with the patient health questionnaire (PHQ)-2 for screening for possible cases of depression among patients newly diagnosed with advanced cancer.

Palliat Support Care 2014 Feb;12(1):63-8

Yale University School of Nursing, New Haven, Connecticut.

Objective: Distress screening guidelines call for rapid screening for emotional distress at the time of cancer diagnosis. The purpose of this study was to examine the distress thermometer's (DT) ability to screen in patients in treatment for advanced cancer who may be depressed.

Methods: Using cross-sectional data collected from patients within 30 days of diagnosis with advanced cancer, this study used ROC analysis to determine the optimal-cutoff point of the distress thermometer (DT) for screening for depression as measured by the physician health questionnaire (PHQ)-9; inter-test reliability analysis to compare the DT with the PHQ-2 for screening in possible cases of depression, and multivariate analysis to examine associations among the DT emotional problem list (EPL) items with cases of depression. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S1478951513000394DOI Listing
February 2014
13 Reads

[Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"].

Authors:
Dolores Gallardo-Rincón David Cantú-de-León Patricia Alanís-López Miguel Angel Alvarez-Avitia Joel Bañuelos-Flores Guillermo Sidney Herbert-Núñez Luis Fernando Oñate-Ocaña María Delia Pérez-Montiel Amelia Rodríguez-Trejo Eva Ruvalcaba-Limón Alberto Serrano-Olvera Andrea Ortega-Rojo Patricia Cortés-Esteban Aura Erazo-Valle Raquel Gerson-Cwilich Jaime De-la-Garza-Salazar Dan Green-Renner Eucario León-Rodríguez Flavia Morales-Vásquez Andrés Poveda-Velasco José Luis Aguilar-Ponce Luis Felipe Alva-López Salvador Alvarado-Aguilar Isabel Alvarado-Cabrero Cinthia Alejandra Aquino-Mendoza Carlos Eduardo Aranda-Flores Artfy Bandera-Delgado Eduardo Barragán-Curiel Patricia Barrón-Rodríguez Rocío Brom-Valladares Paula Anel Cabrera-Galeana Germán Calderillo-Ruiz Salvador Camacho-Gutiérrez Daniel Capdeville-García Jesús Cárdenas-Sánchez Elisa Carlón-Zárate Oscar Carrillo-Garibaldi Gerardo Castorena-Roji Guadalupe Cervantes-Sánchez Jaime Alberto Coronel-Martínez José Gregorio Chanona-Vilchis Verónica Díaz-Hernández Pedro Escudero-de-los Ríos Olga Garibay-Cerdenares Eva Gómez-García Luis Alonso Herrera-Montalvo Luz María Hinojosa-García David Isla-Ortiz Josefina Jiménez-López Arturo Javier Lavín-Lozano Jesús Alberto Limón-Rodriguez Horacio Noé López-Basave Sergio César López-García Antonio Maffuz-Aziz Jorge Martínez-Cedillo Dulce María Martínez-López Juan Manuel Medina-Castro Carlos Melo-Martínez Carmen Méndez-Herrera Gonzalo Montalvo-Esquivel Miguel Angel Morales-Palomares Andrés Morán-Mendoza Gilberto Morgan-Villela Aída Mota-García David Eduardo Muñoz-González Francisco J Ochoa-Carrillo Maricruz Pérez-Amador Edgar Recinos-Money Samuel Rivera-Rivera Juan U Robles Flores Edith Rojas-Castillo Carlos Rojas-Marín Efraín Salas-Gonzáles Liliana Sámano-Nateras Miguel Santibañez-Andrade Antonio Santillán-Gómez Araceli Silva-García Juan Alejandro Silva Gilberto Solorza-Luna Adán Raúl Tabarez-Ortiz Patricia Talamás-Rohana Laura Leticia Tirado-Gómez Alfonso Torres-Lobatón Félix Quijano-Castro

Rev Invest Clin 2011 Nov-Dec;63(6):665-702

Instituto Nacional de Cancerología, Tlalpan, Mexico.

Introduction: Ovarian cancer (OC) is the third most common gynecologic malignancy worldwide. Most of cases it is of epithelial origin. At the present time there is not a standardized screening method, which makes difficult the early diagnosis. Read More

View Article

Download full-text PDF

Source
June 2013
39 Reads

Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer.

Curr Oncol Rep 2009 Jul;11(4):287-92

Division of Gynecologic Oncology, University Hospitals Case Medical Center, 11100 Euclid Avenue, MacDonald Women's Hospital, Cleveland, OH 44106, USA.

The management of malignant bowel obstruction is a challenging problem because of the poor definition of malignant bowel obstruction compounded by its myriad clinical presentations. Surgeons are called upon to perform invasive procedures designed to alleviate symptoms or correct the underlying obstruction. Unfortunately, interventions may carry a high rate of morbidity and mortality. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s11912-009-0040
Web Search
July 2009
4 Reads

Palliative radiation therapy.

Semin Oncol 2005 Apr;32(2):156-64

Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.

Radiation is an effective modality to aid in symptom management of patients with metastatic disease. The type and duration of treatment depends on the Karnofsky performance status (KPS) of the patient and type and status of the cancer. Abbreviated treatment regimens may be favored in this patient population. Read More

View Article

Download full-text PDF

Source
April 2005
5 Reads

[Current surgical management in ovarian cancer recurrences].

Minerva Ginecol 2004 Oct;56(5):457-67

Unità Operativa di Ginecologia e Ostetricia, Ospedale Vito Fazzi, Lecce, Italy.

Ovarian cancer is a tumor with a high trend of recurrence and this occurrence consistently increases the difficulty of the patient cure and reduces the efficacy of current treatments. The role of surgery in persistent or recurrent ovarian cancer is controversial and the type of surgery can be different according to the different stages and invasion of tumor; it can be a debulking surgery followed by chemotherapy (to eradicate the most part of ovarian cancer, leaving a minimal tumoral residue), an interval surgery (for advanced ovarian cancer stage in previously operated patients, followed by 2 or 3 inductive chemotherapy cycles and subsequently a cytoreductive redo surgery) and a cytoreductive secondary surgery, after optimal primary surgical treatment and minimal tumoral recurrence. In some cases it is possible either to perform a debulking surgery during a primary (after the conclusion of primary treatment) or a salvage or palliative surgery (to improve, after an acceptable time period, clinical symptoms in patients with progressive cancer or resistant to treatments). Read More

View Article

Download full-text PDF

Source
October 2004
6 Reads

[Results of 108 exenteration operations in advanced gynecologic cancers].

Authors:
V Friedberg

Geburtshilfe Frauenheilkd 1989 May;49(5):423-7

Universitäts-Frauenklinik Mainz.

We can now say that in our opinion exenteration is not an operation that is dangerous to life, if the conditions that will be described below are observed and if the indication is interpreted sufficiently narrowly, although during the first few years results had been moderate indeed. Exenteration has since developed so positively that it is now increasingly possible to consider the aspect of preserving the function of the adjacent organs, so that the disadvantages resulting for the patient's own body image and her self-concept and self-appraisal are now relatively acceptable compared to what had been possible previously. Indication for exenteration results from the situation, the ideas and the motivation of the patient, mainly, however, against the background of the characteristic features of the operation described here. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1036395DOI Listing
May 1989
5 Reads

1000 cGy single dose palliation for advanced carcinoma of the cervix or endometrium.

Int J Radiat Oncol Biol Phys 1986 Nov;12(11):1947-50

Between January 1980 and the present, 42 patients with symptomatic, incurable gynecologic malignancies were treated at the University of North Carolina with 1000 cGy in a single fraction to the pelvis, repeated once or twice at monthly intervals as necessary. Of patients with adequate follow-up, total cessation of bleeding was seen in 18 of 30 (60%), complete pain relief in 2/9 (22%), and complete tumor eradication in 7/28 (25%). These palliative benefits were permanent in approximately half of the patients. Read More

View Article

Download full-text PDF

Source
November 1986
3 Reads

Single-fraction palliative pelvic radiation therapy in gynecologic oncology: 1,000 rads.

Am J Obstet Gynecol 1984 Mar;148(5):701-5

The management of the patient with advanced gynecologic malignancies presents multiple problems for the gynecologic and radiation oncologists involved in their care. When palliative management only is indicated, conventional treatment protocols occupy a significant portion of the patient's remaining life span, often times with associated morbidity. Single-fraction external radiation therapy, consisting of 1,000 rads to the whole pelvis, was used in 30 patients with advanced gynecologic malignancies to palliate locally advanced pelvic disease. Read More

View Article

Download full-text PDF

Source
March 1984
3 Reads
  • Page 1 of 1